Cancer costs: Marketing and myth busting

More than half of cancer drugs approved in recent years may not be helping patients to live longer. Meanwhile, the average price of cancer drugs has been increasing by 10 percent annually for more...

Unmasking the cost of cancer drug development

Cancer drug R&D spending may be a fraction of the estimate cited by the biopharmaceutical industry. The average price of anticancer drugs has been rising by about 10 percent annually in...